Skip to main content
. 2022 Dec 20;12:21977. doi: 10.1038/s41598-022-26229-4

Table 2.

ROP development and progression, AP-ROP and treatment from 2015 to 2018.

Born 2015 Born 2016 Born 2017 Born 2018 p
ROP development 35 (32.1%) 66 (54.5%) 56 (44.8%) 45 (46.4%) 0.008*
ROP progression 8 (7.3%) 26 (21.5%) 21 (16.8%) 11 (11.3%) 0.015*
Presence AP-ROP 0 (0.0%) 10 (8.3%) 12 (9.6%) 7 (7.2%) 0.016*
ROP treatment 5 (4.6%) 22 (18.2%) 20 (16.0%) 10 (10.3%) 0.009*

*p < 0.005.